Opposite Control of Excitatory and Inhibitory Synapse Formation by Slitrk2 and Slitrk5 on Dopamine Neurons Modulates Hyperactivity Behavior.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
18 02 2020
Historique:
received: 08 01 2018
revised: 03 12 2019
accepted: 24 01 2020
entrez: 21 2 2020
pubmed: 23 2 2020
medline: 10 3 2021
Statut: ppublish

Résumé

The neurodevelopmental origin of hyperactivity disorder has been suggested to involve the dopaminergic system, but the underlying mechanisms are still unknown. Here, transcription factors Lmx1a and Lmx1b are shown to be essential for midbrain dopaminergic (mDA) neuron excitatory synaptic inputs and dendritic development. Strikingly, conditional knockout (cKO) of Lmx1a/b in postmitotic mDA neurons results in marked hyperactivity. In seeking Lmx1a/b target genes, we identify positively regulated Slitrk2 and negatively regulated Slitrk5. These two synaptic adhesion proteins promote excitatory and inhibitory synapses on mDA neurons, respectively. Knocking down Slitrk2 reproduces some of the Lmx1a/b cKO cellular and behavioral phenotypes, whereas Slitrk5 knockdown has opposite effects. The hyperactivity caused by this imbalance in excitatory/inhibitory synaptic inputs on dopamine neurons is reproduced by chronically inhibiting the ventral tegmental area during development using pharmacogenetics. Our study shows that alterations in developing dopaminergic circuits strongly impact locomotor activity, shedding light on mechanisms causing hyperactivity behaviors.

Identifiants

pubmed: 32075770
pii: S2211-1247(20)30118-2
doi: 10.1016/j.celrep.2020.01.084
pii:
doi:

Substances chimiques

LIM homeobox transcription factor 1 beta 0
LIM-Homeodomain Proteins 0
Lmx1a protein, mouse 0
Membrane Proteins 0
Nerve Tissue Proteins 0
Slitrk protein, mouse 0
Slitrk5 protein, mouse 0
Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2374-2386.e5

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Charleen Salesse (C)

CERVO Brain Research Centre, 2601 de la Canardière, Québec, QC G1J 2G3, Canada.

Julien Charest (J)

CERVO Brain Research Centre, 2601 de la Canardière, Québec, QC G1J 2G3, Canada.

Hélène Doucet-Beaupré (H)

CERVO Brain Research Centre, 2601 de la Canardière, Québec, QC G1J 2G3, Canada.

Anne-Marie Castonguay (AM)

CERVO Brain Research Centre, 2601 de la Canardière, Québec, QC G1J 2G3, Canada.

Simon Labrecque (S)

CERVO Brain Research Centre, 2601 de la Canardière, Québec, QC G1J 2G3, Canada.

Paul De Koninck (P)

CERVO Brain Research Centre, 2601 de la Canardière, Québec, QC G1J 2G3, Canada; Department of Biochemistry, Microbiology and Bioinformatics, Faculty of Science and Engineering, Université Laval, Québec, QC G1V 0A6, Canada.

Martin Lévesque (M)

CERVO Brain Research Centre, 2601 de la Canardière, Québec, QC G1J 2G3, Canada; Department of Psychiatry and Neuroscience, Faculty of Medicine, Université Laval, Québec, QC G1V 0A6, Canada. Electronic address: martin.levesque@cervo.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH